Cholinesterase inhibitors – lower risk of heart attack and death in Alzheimer’s disease patients

The group of drugs used in Alzheimer’s disease therapy are cholinesterase inhibitor(ChEI). It turns out that their influence on cranial nerve X and anti-inflammatory action may be useful in prophylaxis of cardiovascular diseases. Authors of a research published in European Heart Journal have shown that ChEI intake may significantly decrease the risk heart attack and death. Read full text »